Cargando…

A review on COVID-19 transmission, epidemiological features, prevention and vaccination

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused hundreds of millions of infections and millions of deaths over past two years. Currently, many countries have still not been able to take the pandemic under control. In this review, we systematically summarized what we have done...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuqin, Wu, Gonghua, Chen, Shirui, Ju, Xu, Yimaer, Wumitijiang, Zhang, Wangjian, Lin, Shao, Hao, Yuantao, Gu, Jing, Li, Jinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047653/
https://www.ncbi.nlm.nih.gov/pubmed/35658107
http://dx.doi.org/10.1515/mr-2021-0023
_version_ 1784695769199017984
author Zhang, Yuqin
Wu, Gonghua
Chen, Shirui
Ju, Xu
Yimaer, Wumitijiang
Zhang, Wangjian
Lin, Shao
Hao, Yuantao
Gu, Jing
Li, Jinghua
author_facet Zhang, Yuqin
Wu, Gonghua
Chen, Shirui
Ju, Xu
Yimaer, Wumitijiang
Zhang, Wangjian
Lin, Shao
Hao, Yuantao
Gu, Jing
Li, Jinghua
author_sort Zhang, Yuqin
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused hundreds of millions of infections and millions of deaths over past two years. Currently, many countries have still not been able to take the pandemic under control. In this review, we systematically summarized what we have done to mitigate the COVID-19 pandemic, from the perspectives of virus transmission, public health control measures, to the development and vaccination of COVID-19 vaccines. As a virus most likely coming from bats, the SARS-CoV-2 may transmit among people via airborne, faecal-oral, vertical or foodborne routes. Our meta-analysis suggested that the R(0) of COVID-19 was 2.9 (95% CI: 2.7–3.1), and the estimates in Africa and Europe could be higher. The median R(t) could decrease by 23–96% following the nonpharmacological interventions, including lockdown, isolation, social distance, and face mask, etc. Comprehensive intervention and lockdown were the most effective measures to control the pandemic. According to the pooled R(0) in our meta-analysis, there should be at least 93.3% (95% CI: 89.9–96.2%) people being vaccinated around the world. Limited amount of vaccines and the inequity issues in vaccine allocation call for more international cooperation to achieve the anti-epidemic goals and vaccination fairness.
format Online
Article
Text
id pubmed-9047653
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-90476532022-06-04 A review on COVID-19 transmission, epidemiological features, prevention and vaccination Zhang, Yuqin Wu, Gonghua Chen, Shirui Ju, Xu Yimaer, Wumitijiang Zhang, Wangjian Lin, Shao Hao, Yuantao Gu, Jing Li, Jinghua Med Rev (Berl) Review Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused hundreds of millions of infections and millions of deaths over past two years. Currently, many countries have still not been able to take the pandemic under control. In this review, we systematically summarized what we have done to mitigate the COVID-19 pandemic, from the perspectives of virus transmission, public health control measures, to the development and vaccination of COVID-19 vaccines. As a virus most likely coming from bats, the SARS-CoV-2 may transmit among people via airborne, faecal-oral, vertical or foodborne routes. Our meta-analysis suggested that the R(0) of COVID-19 was 2.9 (95% CI: 2.7–3.1), and the estimates in Africa and Europe could be higher. The median R(t) could decrease by 23–96% following the nonpharmacological interventions, including lockdown, isolation, social distance, and face mask, etc. Comprehensive intervention and lockdown were the most effective measures to control the pandemic. According to the pooled R(0) in our meta-analysis, there should be at least 93.3% (95% CI: 89.9–96.2%) people being vaccinated around the world. Limited amount of vaccines and the inequity issues in vaccine allocation call for more international cooperation to achieve the anti-epidemic goals and vaccination fairness. De Gruyter 2022-03-02 /pmc/articles/PMC9047653/ /pubmed/35658107 http://dx.doi.org/10.1515/mr-2021-0023 Text en © 2021 Yuqin Zhang et al., published by De Gruyter, Berlin/Boston https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Review
Zhang, Yuqin
Wu, Gonghua
Chen, Shirui
Ju, Xu
Yimaer, Wumitijiang
Zhang, Wangjian
Lin, Shao
Hao, Yuantao
Gu, Jing
Li, Jinghua
A review on COVID-19 transmission, epidemiological features, prevention and vaccination
title A review on COVID-19 transmission, epidemiological features, prevention and vaccination
title_full A review on COVID-19 transmission, epidemiological features, prevention and vaccination
title_fullStr A review on COVID-19 transmission, epidemiological features, prevention and vaccination
title_full_unstemmed A review on COVID-19 transmission, epidemiological features, prevention and vaccination
title_short A review on COVID-19 transmission, epidemiological features, prevention and vaccination
title_sort review on covid-19 transmission, epidemiological features, prevention and vaccination
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047653/
https://www.ncbi.nlm.nih.gov/pubmed/35658107
http://dx.doi.org/10.1515/mr-2021-0023
work_keys_str_mv AT zhangyuqin areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT wugonghua areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT chenshirui areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT juxu areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT yimaerwumitijiang areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT zhangwangjian areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT linshao areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT haoyuantao areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT gujing areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT lijinghua areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT zhangyuqin reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT wugonghua reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT chenshirui reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT juxu reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT yimaerwumitijiang reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT zhangwangjian reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT linshao reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT haoyuantao reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT gujing reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination
AT lijinghua reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination